Literature DB >> 8032872

Enhancement of neuronal calcium channel currents by the nootropic agent, nefiracetam (DM-9384), in NG108-15 cells.

M Yoshii1, S Watabe.   

Abstract

Effects of nootropic agents on neuronal calcium channels were studied in NG108-15 cells using the whole-cell patch-clamp technique. Nefiracetam (DM-9384) at a concentration of 1 microM increased a long-lasting component of calcium channel currents two-fold without affecting a transient component. The dose-response relationship yielded a bell-shaped curve with a peak at 1 microM. Similar, but slightly less potent effects were observed by aniracetam. Dibutyryl cyclic AMP (1 mM) also enhanced the currents, which were not further increased by nefiracetam, or vice versa. The currents enhanced by nefiracetam were markedly reduced by nifedipine (10 microM), an 'L-type' calcium channel blocker. Cells treated with pertussis toxin (PTX; 500 ng/ml, > 20 h) to inactivate inhibitory G-proteins were apparently insensitive to nefiracetam. The results suggest that the nootropic agents may enhance the activity of neuronal L-type calcium channels under the regulation of inhibitory G-proteins and possibly, cyclic AMP-dependent processes.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8032872     DOI: 10.1016/0006-8993(94)90913-x

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  11 in total

1.  Cyclic GTP imitates the potentiating effect of the nootrope vinpocetine on the high-threshold A-current in mollusk neurons.

Authors:  E I Solntseva
Journal:  Neurosci Behav Physiol       Date:  1999 Nov-Dec

2.  Nootropic agent vinpocetine blocks delayed rectified potassium currents more strongly than high-threshold calcium currents.

Authors:  E I Solntseva
Journal:  Neurosci Behav Physiol       Date:  1998 Mar-Apr

Review 3.  CACNA1C (Cav1.2) in the pathophysiology of psychiatric disease.

Authors:  Shambhu Bhat; David T Dao; Chantelle E Terrillion; Michal Arad; Robert J Smith; Nikolai M Soldatov; Todd D Gould
Journal:  Prog Neurobiol       Date:  2012-06-15       Impact factor: 11.685

4.  Improvement by nefiracetam of beta-amyloid-(1-42)-induced learning and memory impairments in rats.

Authors:  K Yamada; T Tanaka; T Mamiya; T Shiotani; T Kameyama; T Nabeshima
Journal:  Br J Pharmacol       Date:  1999-01       Impact factor: 8.739

5.  Piracetam-induced changes in the functional activity of neurons as a possible mechanism for the effects of nootropic agents.

Authors:  L P Derzhiruk
Journal:  Neurosci Behav Physiol       Date:  1996 Nov-Dec

6.  Nefiracetam (DM-9384) reverses apomorphine-induced amnesia of a passive avoidance response: delayed emergence of the memory retention effects.

Authors:  E Doyle; K M O'Boyle; T Shiotani; C M Regan
Journal:  Neurochem Res       Date:  1996-06       Impact factor: 3.996

7.  Nefiracetam enhances acetylcholine outflow from the frontal cortex: in vivo microdialysis study in the rat.

Authors:  S Kawajiri; K Taniguchi; T Sakurai; T Yamasaki
Journal:  J Neural Transm Gen Sect       Date:  1994

8.  Role of L-type Ca2+ channel isoforms in the extinction of conditioned fear.

Authors:  Perrine Busquet; Alfred Hetzenauer; Martina J Sinnegger-Brauns; Jörg Striessnig; Nicolas Singewald
Journal:  Learn Mem       Date:  2008-04-25       Impact factor: 2.460

9.  Dopaminergic D1 receptor signalling is necessary, but not sufficient for cued fear memory destabilisation.

Authors:  Charlotte R Flavell; Jonathan L C Lee
Journal:  Psychopharmacology (Berl)       Date:  2019-08-07       Impact factor: 4.530

Review 10.  Retrieval-Dependent Mechanisms Affecting Emotional Memory Persistence: Reconsolidation, Extinction, and the Space in Between.

Authors:  Zuzana Vaverková; Amy L Milton; Emiliano Merlo
Journal:  Front Behav Neurosci       Date:  2020-09-29       Impact factor: 3.558

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.